FindTrial
Sign In

Clinical study for the treatment of aged acute myeloid leukemia by azacytidine combined with homoharringtonine

Clinical study for the treatment of aged acute myeloid leukemia by azacytidine combined with homoharringtonine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021315
Enrollment
Unknown
Registered
2019-02-13
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myeloid leukemia

Interventions

Case Series:Azacitidine plus Homoharringtonine

Sponsors

Xinqiao Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients with acute myeloid leukemia who meet the diagnostic criteria, aged 60 years or above, have a KPS score of 60 or above.

Exclusion criteria

Exclusion criteria: Patients with severe infection and organ failure.

Design outcomes

Primary

MeasureTime frame
Complte response;Survival rate;???????? ???????? Hematopoietic recovery time of bone marrow;—

Secondary

MeasureTime frame
Incidence of infection;Relapse rate;—

Countries

China

Contacts

Public ContactYao Han

Department of Hematology, Xinqiao Hospital Affiliated to Army Medical University

marieyaohanhan@outlook.com+86 13996014516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026